Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

Similar articles for PubMed (Select 20514160)

1.

Tuberculosis screening and active tuberculosis among HIV-infected persons in a Canadian tertiary care centre.

Brassard P, Hottes TS, Lalonde RG, Klein MB.

Can J Infect Dis Med Microbiol. 2009 Summer;20(2):51-7.

2.

A prospective study of the risk of tuberculosis among HIV-infected patients.

Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, Aznar E, Miró JM, Mallolas J, Zamora L, González J, et al.

AIDS. 1993 Oct;7(10):1345-9.

PMID:
8267907
3.

Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.

Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H; Swiss HIV Cohort Study.

Clin Infect Dis. 2007 Jan 1;44(1):94-102. Epub 2006 Nov 28.

4.

Low adherence to guidelines for preventing TB among persons with newly diagnosed HIV infection, United States.

Lee LM, Lobato MN, Buskin SE, Morse A, Costa OS.

Int J Tuberc Lung Dis. 2006 Feb;10(2):209-14.

PMID:
16499263
5.

Screening for active tuberculosis in HIV testing centre.

Espinal MA, Reingold AL, Koenig E, Lavandera M, Sanchez S.

Lancet. 1995 Apr 8;345(8954):890-3.

PMID:
7707812
6.

Potentially preventable tuberculosis among HIV-infected persons in the era of highly active antiretroviral treatment.

Pettit AC, Barkanic G, Stinnette S, Rebeiro P, Blackwell R, Raffanti SP, Shepherd BE, Sterling TR.

Int J Tuberc Lung Dis. 2009 Mar;13(3):355-9.

7.

Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.

Martín-Echevarria E, Rodríguez-Zapata M, Torralba M, Fernández JM, Moreno A, Casado JL, Dronda F, Pérez-Elías MJ, Navas E, Moreno S.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1347-52. doi: 10.5588/ijtld.10.0686.

PMID:
22283893
8.

Using tuberculin skin test as an entry point to screen for latent and active tuberculosis in Thai people living with HIV.

Phanuphak N, Varma JK, Kittikraisak W, Teeratakulpisarn N, Phasitlimakul S, Suwanmala P, Pankam T, Burapat T, Tasaneeyapan T, McCarthy KD, Cain KP, Phanuphak P.

J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):384-92. doi: 10.1097/QAI.0b013e318258c675.

PMID:
22531757
9.

Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.

Gupta A, Nayak U, Ram M, Bhosale R, Patil S, Basavraj A, Kakrani A, Philip S, Desai D, Sastry J, Bollinger RC; Byramjee Jeejeebhoy Medical College-Johns Hopkins University Study Group.

Clin Infect Dis. 2007 Jul 15;45(2):241-9. Epub 2007 Jun 4.

10.

Tuberculin skin test results in HIV-infected patients in India: implications for latent tuberculosis treatment.

Swaminathan S, Subbaraman R, Venkatesan P, Subramanyam S, Kumar SR, Mayer KH, Narayanan PR.

Int J Tuberc Lung Dis. 2008 Feb;12(2):168-73.

PMID:
18230249
11.

Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.

[No authors listed]

MMWR Recomm Rep. 1997 Sep 5;46(RR-15):1-10. Erratum in: MMWR Morb Mortal Wkly Rep 1997 Sep 19;46(37):880.

12.

Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants.

Orlando G, Merli S, Cordier L, Mazza F, Casazza G, Villa AM, Codecasa L, Negri E, Cargnel A, Ferrarese M, Rizzardini G.

Infection. 2010 Jun;38(3):195-204. doi: 10.1007/s15010-010-0015-2. Epub 2010 Apr 22.

PMID:
20411295
13.

TB prevention in HIV clinics in New York City.

Sackoff JE, Torian LV, Frieden TR.

Int J Tuberc Lung Dis. 2001 Feb;5(2):123-8.

PMID:
11258505
14.

Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.

Aisu T, Raviglione MC, van Praag E, Eriki P, Narain JP, Barugahare L, Tembo G, McFarland D, Engwau FA.

AIDS. 1995 Mar;9(3):267-73.

PMID:
7755915
15.

Diagnosing latent tuberculosis infection in the HIV era.

Lagrange PH, Herrmann JL.

Open Respir Med J. 2008;2:52-9. doi: 10.2174/1874306400802010052. Epub 2008 May 23.

16.

Yield of tuberculin screening among injection drug users.

Brassard P, Bruneau J, Schwartzman K, Sénécal M, Menzies D.

Int J Tuberc Lung Dis. 2004 Aug;8(8):988-93.

PMID:
15305482
18.

Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.

Kassa A, Teka A, Shewaamare A, Jerene D.

Trans R Soc Trop Med Hyg. 2012 Jun;106(6):363-70. doi: 10.1016/j.trstmh.2012.03.002. Epub 2012 Apr 20.

PMID:
22521216
19.

The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.

Braitstein P, Nyandiko W, Vreeman R, Wools-Kaloustian K, Sang E, Musick B, Sidle J, Yiannoutsos C, Ayaya S, Carter EJ.

Pediatr Infect Dis J. 2009 Jul;28(7):626-32. doi: 10.1097/INF.0b013e31819665c5.

PMID:
19451858
20.

Targeted testing of children for tuberculosis: validation of a risk assessment questionnaire.

Froehlich H, Ackerson LM, Morozumi PA; Pediatric Tuberculosis Study Group of Kaiser Permanente, Northern California.

Pediatrics. 2001 Apr;107(4):E54.

PMID:
11335775
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk